Back to Agenda
Electronic Labeling: Where are we Now and What are the Next Steps in the World?
Session Chair(s)
Rie Matsui, RPH
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
The most updated eLabeling initiatives in the US, EU, Canada, and Japan, and the trends for eLabeling in emerging markets will be shared. The possibility of the convergence of the eLabeling initiatives will be discussed in the digital health.v
Learning Objective : Describe the most updated electronic labeling initiatives in the US, EU, Canada, Japan, and emerging countries; Discuss the possibility of the convergence for electronic labeling across regions.
Speaker(s)
Shinobu Uzu, PHD
Senior Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
eLabeling Updates in Japan and Collaboration with Asia Countries
Elizabeth Scanlan, PHD, MSC
ePI Product Owner, European Medicines Agency, Netherlands
Electronic Product Information (ePI) in the EU: Progress and the Road Ahead
Christine Wood, PHD
Global Labeling TA Director (Respiratory and Immunology), AstraZeneca, United Kingdom
Behind the Scenes in Implementing eLabeling: COVID-19 Vaccine Label Development During a Global Pandemic
Have an account?